glp-1 and gip hormones Major physiological roles of GIP. Tirzepatide is acting as an The mechanism of GLP-1 and

In several clinical trials, Semaglutide GLP-1 has been found to be safe and effective for up to 2 years of treatment

Early prediction of severe acute pancreatitis using machine learning

Executive Summary Quick Insight: The GLP-1 Weight Loss Drug Market is on track to more than double to USD 192 billion by 2035 , driven by explosive patient demand for injectable and oral incretin therapies, multi-indication label expansion beyond obesity into cardiovascular protection and metabolic disease management, a robust late-stage pipeline of next-generation triple agonists, and unprecedented payer engagement transforming obesity into a fully reimbursable chronic disease requiring long-term pharmacological management

Patients relying on compounded tirzepatide faced transitions to pharmaceutical-grade products or sought alternative therapies